Oncolytics Biotech Inc (NAS:ONCY)
$ 0.97 0 (0%) Market Cap: 75.59 Mil Enterprise Value: 62.70 Mil PE Ratio: 0 PB Ratio: 10.78 GF Score: 31/100

Oncolytics Biotech Inc Annual Shareholders Meeting Transcript

May 02, 2019 / 08:30PM GMT
Release Date Price: $1.95 (+1.56%)
Matthew C. Coffey
Oncolytics Biotech Inc. - President, CEO & Director

Are we good? Thank you, everyone, for coming to the Annual General Meeting. I'll direct your attention to our forward-looking statements. Today's presentation is a little bit different. We are assuming because everyone here is likely a shareholder, that they probably know the story. So we wanted to talk more, a little bit about what the last 12 months have happened, the importance of the biomarker, what we are doing on BD. I'm going to invite my colleagues, Miss Allison Hagerman to come up and speak about the manufacturing. Andrew will be talking -- Andrew de Guttadauro will be talking about our BD efforts and what we're doing and how we are moving this forward, and how we're going to create a competitive environment. And finally, Mr. Look will be giving an overview of what's going on within the business of the organization.

Now pelareorep. Try not to think of it as a virus. I know this sounds counterintuitive. But what it is, it's an immune oncology (sic) [immuno-oncolytic] virus that is systemically delivered. And really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot